Epsilon M&A Deal Report - Universal Products Lytham (UPL) Manufacturing (now Laleham Health & Beauty)
Transaction Multiples for the Valuation of Private Companies
DCC / Universal Products Lytham (UPL) Manufacturing (now Laleham Health & Beauty)
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
Current |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
- Number of EMAT Reports / sub-sector « Personal Products » = 133
Date | Acquirer | Target | Country | Multiples | See details |
23/04/2015 | Biosynex | Prodiag | France | *** | 78171 |
14/09/2015 | Cantel Medical | Medical Innovations Group Holdings | United Kingdom | *** | 78155 |
Source: Epsilon Research / EMAT